Page 1 of Clinical Trials for Novartis Vaccines [SPONSOR-COLLABORATORS], 186 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults
Last Updated: March 12, 2012
Condition(s): Influenza Disease; Flu
2
Completed
Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)
Last Updated: April 5, 2012
Condition(s): Typhoid Fever
3
Completed
Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)
Last Updated: November 23, 2010
Condition(s): Typhoid Fever
4
Active, not recruiting
Safety, Reactogenicity and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants
Last Updated: April 5, 2012
Condition(s): Typhoid Fever
5
Active, not recruiting
Safety, Reactogenicity and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants
Last Updated: April 5, 2012
Condition(s): Typhoid Fever
6
Completed
Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults
Last Updated: April 5, 2012
Condition(s): Typhoid Fever
7
Completed
Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months
Last Updated: December 7, 2011
Condition(s): Influenza
8
Recruiting
Safety of MenACWY-CRM Vaccination in Adolescents
Last Updated: May 9, 2012
Condition(s): Meningococcal Disease
9
Completed
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age
Last Updated: October 7, 2011
Condition(s): Pandemic Influenza
10
Completed
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)
Last Updated: April 22, 2011
Condition(s): Novel 2009 Influenza H1N1
11
Completed
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
Last Updated: February 2, 2012
Condition(s): Meningococcal Disease; Meningococcal Meningitis
12
Recruiting
Extent of the Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in HIV Positive and HIV Negative Pregnant Women and Their Offsprings.
Last Updated: May 2, 2012
Condition(s): Streptococcal Infections; Gram-Positive Bacterial Infections; Bacterial Infections
13
Recruiting
A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older
Last Updated: January 23, 2012
Condition(s): Influenza (Seasonal)
14
Completed
Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (18-60 Years)
Last Updated: March 6, 2012
Condition(s): Influenza
15
Completed
Safety and Immunogenicity (Non-inferiority) of a Purified Chick Embryo Cell Vaccine Vaccine Administered in Two Different Schedules (Conventional Versus Abbreviated Schedule)
Last Updated: December 7, 2011
Condition(s): Rabies
16
Completed
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age
Last Updated: October 10, 2011
Condition(s): Pandemic Influenza
17
Completed
Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects
Last Updated: January 4, 2012
Condition(s): Swine-Origin Influenza A H1N1 Virus
18
Completed
Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Last Updated: October 21, 2011
Condition(s): Meningococcal Disease
19
Completed
Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009
Last Updated: November 4, 2011
Condition(s): Seasonal Influenza, Vaccine
20
Completed
A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months
Last Updated: March 6, 2012
Condition(s): Meningococcal Disease

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Novartis+Vaccines

Page 1 of Clinical Trials for Novartis Vaccines [SPONSOR-COLLABORATORS], 186 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About